AAAAAA
Results:
1-7
|
Results: 7
Authors:
Sutton, L
Swinehart, JM
Cato, A
Kaplan, AS
Citation: L. Sutton et al., A clinical study to determine the efficacy and safety of 1% methotrexate/Azone (R) (MAZ) gel applied topically once daily in patients with psoriasis vulgaris, INT J DERM, 40(7), 2001, pp. 464-467
Authors:
Cato, A
Swinehart, JM
Griffin, EI
Sutton, L
Kaplan, AS
Citation: A. Cato et al., Atone (R) enhances clinical effectiveness of an optimized formulation of triamcinolone acetonide in atopic dermatitis, INT J DERM, 40(3), 2001, pp. 232-236
Authors:
Cato, A
Sutton, L
Manning, GN
Kaplan, AS
Citation: A. Cato et al., Activity of a 0.05% triamcinolone acetonide/laurocapram formulation: Double-blind, randomized comparison with standard 0.1% triamcinolone acetonide creams and with mild (class VI) to potent (class III) topical corticosteroids, CURR THER R, 62(4), 2001, pp. 231-235
Authors:
Cato, A
Sutton, L
Kaplan, AS
Manning, GN
Citation: A. Cato et al., Activity of a triamcinolone acetonide/laurocapram formulation: Double-blind comparisons with triamcinolone acetonide, placebo vehicle, and mid-strength (Class IV) to potent (Class II) corticosteroids, CURR THER R, 62(3), 2001, pp. 180-186
Authors:
Soignet, SL
Miller, VA
Pfister, DG
Bienvenu, BJ
Ho, R
Parker, BA
Amyotte, SA
Cato, A
Warrell, RP
Citation: Sl. Soignet et al., Initial clinical trial of a high-affinity retinoic acid receptor ligand (LGD1550), CLIN CANC R, 6(5), 2000, pp. 1731-1735
Authors:
Miller, WH
Reyno, LM
Loewen, GR
Huan, S
Winquist, E
Moore, M
Cato, A
Jaunakais, D
Truglia, JA
Matthews, S
Dancey, J
Eisenhauer, E
Citation: Wh. Miller et al., A phase I-II study of 9-cis retinoic acid and interferon-alpha 2b in patients with advanced renal-cell carcinoma: An NCIC Clinical Trials Group study, ANN ONCOL, 11(11), 2000, pp. 1387-1389
Authors:
Cato, A
Citation: A. Cato, The Core Bibliographic Record for Music and Sound Recordings (An IAML Working Group), FON ART MUS, 45(2), 1998, pp. 139-151
Risultati:
1-7
|